SIO GENE THERAPIES INC - COMMON (SIOX)

CUSIP: 829399104

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COMMON
Total 13F shares
20,366,519
Share change
+6,137,430
Total reported value
$53,173,003
Put/Call ratio
167%
Price per share
$2.61
Number of holders
47
Value change
+$15,816,843
Number of buys
22
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 829399104?
CUSIP 829399104 identifies SIOX - SIO GENE THERAPIES INC - COMMON in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SIO GENE THERAPIES INC - COMMON (SIOX) as of Q1 2021

As of 31 Mar 2021, SIO GENE THERAPIES INC - COMMON (SIOX) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,366,519 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, Consonance Capital Management LP, Rubric Capital Management LP, Opaleye Management Inc., Hudson Bay Capital Management LP, VANGUARD GROUP INC, TWO SIGMA INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC, Sio Capital Management, LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 47 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.